Stock Traders Buy High Volume of Call Options on OraSure Technologies (OSUR)

OraSure Technologies, Inc. (NASDAQ:OSUR) saw unusually large options trading on Thursday. Stock traders bought 1,682 call options on the company. This represents an increase of 686% compared to the average volume of 214 call options.

Shares of OraSure Technologies (OSUR) opened at $18.00 on Friday. OraSure Technologies has a twelve month low of $9.92 and a twelve month high of $23.01. The firm has a market capitalization of $1,066.20, a PE ratio of 35.29, a P/E/G ratio of 3.91 and a beta of 1.43.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings data on Wednesday, February 7th. The medical instruments supplier reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.01. OraSure Technologies had a return on equity of 13.09% and a net margin of 18.52%. The company had revenue of $52.00 million during the quarter, compared to analyst estimates of $50.20 million. During the same quarter last year, the firm posted $0.13 EPS. The firm’s revenue for the quarter was up 46.5% on a year-over-year basis. analysts anticipate that OraSure Technologies will post 0.36 earnings per share for the current year.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Oppenheimer Asset Management Inc. purchased a new position in OraSure Technologies during the 3rd quarter valued at about $186,000. ARP Americas LLC purchased a new position in OraSure Technologies during the 3rd quarter valued at about $221,000. Noesis Capital Mangement Corp purchased a new position in OraSure Technologies during the 3rd quarter valued at about $225,000. Profund Advisors LLC grew its holdings in OraSure Technologies by 2.8% during the 2nd quarter. Profund Advisors LLC now owns 10,903 shares of the medical instruments supplier’s stock valued at $188,000 after buying an additional 293 shares in the last quarter. Finally, Shikiar Asset Management Inc. purchased a new position in OraSure Technologies during the 4th quarter valued at about $207,000. 92.29% of the stock is owned by institutional investors.

A number of equities research analysts have recently commented on OSUR shares. Zacks Investment Research cut OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. BidaskClub upgraded OraSure Technologies from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 20th. Jefferies Group reiterated a “buy” rating and set a $23.00 target price on shares of OraSure Technologies in a research note on Friday, October 20th. ValuEngine cut OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Finally, Canaccord Genuity reiterated a “buy” rating and set a $24.00 target price on shares of OraSure Technologies in a research note on Friday, February 2nd. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $22.25.

ILLEGAL ACTIVITY NOTICE: “Stock Traders Buy High Volume of Call Options on OraSure Technologies (OSUR)” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://www.com-unik.info/2018/02/11/stock-traders-buy-high-volume-of-call-options-on-orasure-technologies-osur.html.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit